0001125345-22-000032.txt : 20220224 0001125345-22-000032.hdr.sgml : 20220224 20220224194900 ACCESSION NUMBER: 0001125345-22-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220222 FILED AS OF DATE: 20220224 DATE AS OF CHANGE: 20220224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Spitznagel Thomas CENTRAL INDEX KEY: 0001675464 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36112 FILM NUMBER: 22673745 MAIL ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MACROGENICS INC CENTRAL INDEX KEY: 0001125345 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: Rockville STATE: MD ZIP: 20850 BUSINESS PHONE: 301-251-5172 MAIL ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 wf-form4_164575011929211.xml FORM 4 X0306 4 2022-02-22 0 0001125345 MACROGENICS INC MGNX 0001675464 Spitznagel Thomas 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 0 1 0 0 Sr VP, Technical Ops Employee stock option (right to buy) 10.15 2022-02-22 4 A 0 140000 0 A 2032-02-22 Common Stock 140000.0 140000 D 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter. /s/ Lynn Cilinski, Attorney-in-Fact 2022-02-24